BALB/c 및 NC/Nga 마우스의 아토피성 피부질환모델에서 생약조성물 SPZZC의 치료효능 = Effect of SPZZC, a Composition of Herb Extracts, on Atopic Dermatitis in BALB/c and NC/Nga Mouse

다국어 초록 (Multilingual Abstract)

The aim of this study was to evaluate if a composition of herb extracts, PLX-PLS was effective to treat atopic dermatitis (AD) in mice. SPZZC is a composition of herb extracts containing the roots of Scopolia parviflora and Paeonia lactiflora, the herb of Zizania caudiflora, the fruit of Ziziphus jujuba and the leaf of Chinese arborvitae. AD in BALB/c mouse was induced by patching ovoalbumin on the backside, while it in NC/Nga mouse was induced by repeated application of 1-chloro 2,4-dinitrobenzene (DNCB). Mice were topically treated with SPZZC or Domohorn ointment on the backside for 2 weeks (BALB/c) or 1 week (NC/Nga). Scratching behavior, clinical skin severity and the levels of WBC, neutrophil, eosinophil and total serum IgE were measured. After AD induction, scores of scratching behavior and clinical skin severity and the levels of WBC, neutrophil, eosinophil and total serum IgE were increased. Treatment with SPZZC significantly decreased scores of scratching behavior and clinical skin severity in a dose dependent manner in NC/Nga and BALB/c mice. Treatment with SPZZC 2% significantly decreased also the levels of WBC, neutrophil, eosinophil and total serum IgE. Especially, treatment of SPZZC 2% reduced more rapidly score of clinical skin severity than clobetasol cream. These results suggest that the SPZZC may be an alternative substance for the management of AD.

참고문헌 (Reference)

1 성현철, "아토피피부염에서 임상적 중증도에 따른 알레르기 검사소견" 대한피부과학회 44 (44): 1051-1057, 2006

2 박영립, "아토피피부염 학회보고서: 한국인 아토피피부염의 진단기준에 대한 연구" 대한피부과학회 44 (44): 659-663, 2006

3 박용민, "아토피피부염 병태생리에 대한 최신 지견" 대한 소아알레르기 호흡기학회 16 (16): 189-196, 2006

4 김현애, "실크 단백질 Sericin 및 Fibroin의 식이 공급이 아토피 피부염 동물 모델NC/Nga Mice의 혈장과 표피의 유리 아미노산 함량에 미치는 영향" 한국영양학회 39 (39): 520-528, 2006

5 Aristedis, R., "blood leukocyte count and its prognostic significance in severe head injury" 55 : 190-, 2001

6 Leung, D. Y. M., "Thympopentin therapy reduces the clinical severity of atopic dermatitis" 85 : 927-, 1990

7 White, M. V., "The role of histamine in allergic disease" 86 : 599-, 1990

8 Budde, I. K., "Studies on the association between immunoglobulin E autoreactivity and immunoglobulin E-dependent histamin-releasing factor" 107 : 243-, 2002

9 Kwon, Y. S., "Pharmacognosy" Dmsbooks 186-, 2006

10 Smuith, C. H., "New approaches to topical therapy" 25 : 567-, 2000

11 Suto, H., "NC/Nga mice: a mouse model for atopic dermatitis" 120 : 70-, 1999

12 Charles, L. E., "Interferone-γ. therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement" 92 : 49-, 1999

13 Suzuki, R., "Effects of n-3 polyunsaturated fatty acids of dermatitis in NC/Nga mice. Prostaglandins" 66 (66): 435-, 2002

14 Jun, B. D., "Effects of cortex mori on the compound 48/80-induced anaphylactic shock and histamine release from mast cells" 24 : 193-, 1991

15 Kim, J. S., "Effects of cortex mori on mesenteric mast cells of the rat" 10 : 231-, 1986

16 Kim, G. H., "Effects of Mori folium on the atopic dermatitis" 20 : 37-, 2004

17 Park, S. N., "Effect of Sopungsan in BALB/c mouse model of atopic dermatitis" Graduate School of Kyung-Hee univ. 2002

18 Matsuda, H., "Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice" 9 : 461-, 1997

19 Ikezawa, Y., "Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity" 39 : 105-, 2005

20 Kagi, M. K., "Correlation of eosinophil cationic protein and soluble interleukin-2 receptor with the clinical activity of atopic dermatitis" 185 : 88-, 1992

21 Cho, S. S., "Chinese dermatology" Science Pub 110-, 1999

22 Ichiro, H., "Characterization of dermatitis arising spontaneuously in DSNh mice maintained" 30 : 142-, 2002

23 William, A., "Atopic dermatitis" 53 : 86-, 2005

24 Hiroto, M., "Association of plasma neutrophil elastase levels with other inflammatory mediators and clinical features in adult patients with moderate and severe pneumonia" 101 : 1521-, 2007

25 Norikazu, T., "Analysis of the spontaneuous scratching behavior by NC/Nga mice: a possible apporoach to evaluate antipruritics for subjects with atopic dermatitis" 471 : 223-, 2003

26 Koji, U., "A novel acoustic evaluation system of scratching in mouse dermatitis: Rapid and specific detection of invisibly rapid scratch in an atopic dermatitis model mouse" 79 : 2144-, 2006

27 Choi, Y. S., "A Study on clinical features and laboratory findings according to the severity of atopic dermatitis" 44 : 824-, 2005